This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.

CRA Insights

CRA Insights: Life Sciences: November 2014

November 13, 2014

This newsletter highlights recent thinking and announcements from members of the Life Sciences Practice.

Download

Related capabilities

Life Sciences

Share

Life Sciences
Infographics

Upper Payment Limits (UPLs) explained

Regulatory shifts create new challenges for pharmaceutical stakeholders. Four states now have PDABs empowered to set UPLs for public payers, and three states...
Life Sciences
CRA Insights

The evolving vaccine landscape: Insights from the 6th ESCMID Conference on Vaccines

The conference brought together the vaccine community and stakeholders, including industry representatives, clinicians, regulators, policymakers, academics,...

Explore our thinking

Life Sciences
CRA Hosted Event

January 13, 2026

San Francisco, CA

What Happens if U.S. Pharmaceutical Prices Become the World’s Benchmark?

The U.S. Most Favored Nation (MFN) Executive Order could upend global drug pricing as we know it. Some manufacturers are now vowing to launch only at U.S....